retatrutide fda approval status as of october 2025 This weight-loss drug hasn't been approved by the FDA. Doctors are prescribing it anyway 🚨 “Retatrutide” isn't approved or

While no treatment guarantees success for everyone, having access to medical-grade obesity treatment at an affordable price point, with comprehensive physician support, removes significant obstacles that have prevented many people from getting the help they need

Brand-name Wegovy and Zepbound are sometimes covered for patients with documented obesity (BMI 30+) or BMI 27+ with a comorbid condition

Helps improve metabolism and vitality

Who its for May be a fit if you Have reached your weight goal and want to maintain Want a lower-dose, maintenance-style approach Prefer month-to-month flexibility Want licensed provider oversight and ongoing support Not the right fit if you Are just starting and want active weight loss (consider full-dose GLP-1) Have a personal or family history of medullary thyroid carcinoma or MEN 2 Are pregnant, trying to conceive, or breastfeeding Are advised against GLP-1 care by your provider Eligibility is always determined by a licensed provider after reviewing your intake

Potential applications for anti-aging, include stimulating autophagy, reducing inflammation, and supporting improved wound healing and tissue repair